Global Blood Screening
Market Report
2024
Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Blood Screening Market Report 2024.
Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Blood Screening Market Sales Revenue 2022 | $ 3.61 Billion |
Global Blood Screening Market Sales Revenue 2030 | $ 5.14 Billion |
Global Blood Screening Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Market Split by Product |
|
Market Split by End User |
|
Market Split by Technology |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Blood Screening industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Blood Screening Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Blood screening is the process of analyzing a sample of blood to assess various aspects of an individual's health. It involves the examination of blood components, such as red and white blood cells, platelets, and plasma, and the detection of specific biomarkers, antibodies, hormones, or other substances present in the blood. In addition, the blood screening test is the blood chemistry panel which includes various tests that assess the levels of different chemicals and substances in the blood. Furthermore, this screening helps to monitor diseases and prevent health issues and a variety of other conditions such as infections and cancer. Blood donor screening is the defense mechanism implemented against the spread of infection prior to blood donation.
Increasing need for blood donation due to healthcare systems advancements and the need and availability of sophisticated surgical procedures including blood diseases, cardiovascular, therapy for cancer, transplant surgery, and trauma care. This is expected to drive the growth of the blood screening market. In addition, blood transfusions are generally prescribed in difficult childbearing to prepare for childhood inherited maternal blood disorders, trauma, and acute anemia. Furthermore, increasing blood safety from infectious diseases awareness through various programs. Rising accidents cases and prevalence of chronic diseases such as cancer. This is expected to drive the growth of the blood screening market in the forecast period.
Preventing the blood screening expanding, despite rising rates of transfusion-transmissible illnesses and larger prevalence of HIV, hepatitis B, hepatitis C, and syphilis in developing nations like India, China, and Africa. The lack of funding for healthcare infrastructure in developing nations for blood screening procedures is the key factor restricting the growth of the blood screening market. In addition, high costs related to the test instruments and strict regulatory policies, are some of the factors anticipated to hamper the growth of the blood screening market in the forecast period.
During the COVID-19 pandemic, the blood screening market faced several difficulties including blood donations and collections were significantly decreased as a result of the lockdowns and limitations in the COVID-19 outbreak. In many nations, decreasing blood and blood components and negative effects on blood system operations. Additionally, the number of blood donors has been rising as the limitations are being loosened. The American Red Cross started analyzing all donated plasma, platelets, and blood samples for COVID-19 antibodies. Furthermore, during the pandemic, several companies quickly created a number of serological assays that quickly detect COVID-19 antibodies.
We have various report editions of Blood Screening Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
GRAIL has introduced Galleri, a groundbreaking multi-cancer early-detection blood test
In June 2021, GRAIL introduced the Galleri blood test, which is a multi-cancer early-detection blood test. The company announced Galleri is available in the U.S. by prescription only. This test will help the company screen around 50 million people after its launch and pursue a full FDA approval by 2023.
Top Companies Market Share in Blood Screening Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
In 2022, the North American region dominated the blood screening market and largest market share in terms of revenue. This is attributed to increasing blood donation rates, extensive use of blood screening procedures, and improved patient affordability in the region. Additionally, high level of awareness regarding blood safety among the populace. For instance, the American National Red Cross reported that approximately 6.8 million Americans donate blood annually. Furthermore, the presence of key players and strict FDA regulations for transfusion in the region. This is anticipated to fuel the growth of the blood screening market in the region.
The Asia-Pacific region is expected to largest growth rate in the blood screening market during the forecast period. This is due to increasing awareness among people about blood donation, patient affordability, and the focus of key players on developing countries in the region. The Asia Pacific region's largest contributors include Japan, China, India, Singapore, and Australia. This is expected to drive the growth of the blood screening market in the region during the forecast period.
The current report Scope analyzes Blood Screening Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Blood Screening Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Blood Screening Industry growth. Blood Screening market has been segmented with the help of its Product, End User Technology, and others. Blood Screening market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The reagents & kits segment dominated the blood screening market, in 2022
The reagents & kits segment dominated the blood screening market, in 2022. This is due to high blood testing accuracy with consumer cost-effectiveness. reagents and kits are less expensive than instruments, tests use in greater quantities. In addition, reagents are a recurring expense and are frequently used in molecular and immunoassay procedures. Increasing blood donation, testing connected to transfusions, and the incidence of infectious diseases. This is a factor affecting the growth of this segment in the blood screening market.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Blood Screening Industry. Request a Free Sample PDF!
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Blood Screening from 2019 to 2031. This will also help to analyze the demand for Blood Screening across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key End User of Blood Screening are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Blood Screening Market is witnessing significant growth in the near future.
In 2023, the Instruments segment accounted for noticeable share of global Blood Screening Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Becton Dickinson , Thermo Fisher Scientific Inc. and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Product | Instruments, Software & Services, Reagents & Kits |
End User | Hospitals, Blood Banks |
Technology | Rapid Tests, Nucleic Acid Testing, Western Blot Assays, ELISA, Next Generation Sequencing |
List of Competitors | Becton Dickinson, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics, Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols, Beckman Coulter Inc. |
This chapter will help you gain GLOBAL Market Analysis of Blood Screening. Further deep in this chapter, you will be able to review Global Blood Screening Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Chapter 3 Europe Market Analysis
Chapter 4 Asia Pacific Market Analysis
Chapter 5 South America Market Analysis
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Technology Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Blood Screening market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Instruments have a significant impact on Blood Screening market? |
What are the key factors affecting the Instruments and Software & Services of Blood Screening Market? |
What is the CAGR/Growth Rate of Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Blood Screening Market? |
Which region is expected to dominate the global Blood Screening Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Blood Screening Market
Request Sample